Samplimy Production

Purpose and goal: ** Denna text är maskinöversatt **

Samplimy has developed a product for Point of Care microsampling of biomarkers in interstitial fluid from the skin. The biomarkers can be used to diagnose or follow the course of certain diseases. Samplimy wishes to further develop the existing product prototype in terms of design and function to increase user-friendliness and enable large-scale production.

The objective is to manufacture a zero series of the product that can be used in pilot studies and with a design that is compatible with the eligibility requirements set for FDA/CE marking. Expected results and effects: ** Denna text är maskinöversatt **

An improved version of the current product that is ready to be used in pilot studies on patients and that can be manufactured on a large scale by subcontractors. Approach and implementation: ** Denna text är maskinöversatt **

Samplimy will work with technical consultants experienced in product design, design protection and medical device manufacturing to improve the design and simplify the manufacturing process. Since the product must be able to be used both in healthcare and at home by the patients themselves, Samplimy will continuously have a dialogue with healthcare staff and patients during the process.